Phases of biomarker development for early detection of cancer

Journal of the National Cancer Institute

Volumn 93, Issue 14, 2001, Pages 1054-1061

  Pepe, Margaret Sullivan ^a   Etzioni, Ruth ^b   Feng, Ziding ^b   Potter, John D ^b   Thompson, Mary Lou ^a   Thornquist, Mark ^b   Winget, Marcy ^b   Yasui, Yutaka ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ALGORITHM; ASSAY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RESEARCH; CANCER SCREENING; CLINICAL PROTOCOL; COVARIANCE; DATA ANALYSIS; DEMOGRAPHY; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; HEALTH BEHAVIOR; HEALTH CARE COST; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LABORATORY; LABORATORY DIAGNOSIS; MASS SCREENING; NOTE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REPRODUCIBILITY; RETROSPECTIVE STUDY; SAMPLE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TIME; WESTERN BLOTTING;

EID: 0035908491     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.14.1054     Document Type: Note

References (29)

1. Molecular and genetic targets in early detection
2. Early detection cancer research network
3. Statistical principles for clinical trials
4. New directions in cancer control
5. Epidemiology: A step forward in the scientific approach to preventing cancer through chemoprevention
6. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas
7. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry
8. A framework for clinical evaluation of diagnostic technologies
9. Evaluation of diagnostic systems: Methods from signal detection theory
10. Identifying combinations of cancer markers for further study as triggers of early intervention
11. Receiver operating characteristic methodology
12. A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data
13. Comparison of discrimination methods for the classification of tumors using gene expression data
14. Analyzing a portion of the ROC curve
15. Human neoplasms elicit multiple specific immune responses in the autologous host
16. Incorporating the time dimension in receiver operating characteristic curves: A case study of prostate cancer
17. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET)
18. Comparing disease screening tests when true disease status is ascertained only for screen positives
19. A population-based study of the usefulness of screening for neuroblastoma
20. Is screening for prostate cancer the current gold standard? - "No."
21. Rationale for randomised trials of prostate cancer screening
22. Estimating medical costs from incomplete follow-up data
23. A consistent estimator for the distribution of quality adjusted survival time
24. The asymptotic properties of nonparametric-tests for comparing survival distributions
25. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal and ovarian cancers
26. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute
27. Comparative efficiency of prostate-specific antigen screening strategies for the prostate cancer detection
28. Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening
29. Serial prostate specific antigen screening for prostate cancer: A computer model evaluates competing strategies